Protagonist Net Working Capital from 2010 to 2024
PTGX Stock | USD 29.98 0.43 1.41% |
Net Working Capital | First Reported 2010-12-31 | Previous Quarter 334.3 M | Current Value 227.5 M | Quarterly Volatility 82.7 M |
Check Protagonist Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protagonist main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 M, Interest Expense of 4.1 M or Selling General Administrative of 18 M, as well as many exotic indicators such as Price To Sales Ratio of 20.61, Dividend Yield of 0.0 or PTB Ratio of 4.06. Protagonist financial statements analysis is a perfect complement when working with Protagonist Therapeutics Valuation or Volatility modules.
Protagonist | Net Working Capital |
Latest Protagonist Therapeutics' Net Working Capital Growth Pattern
Below is the plot of the Net Working Capital of Protagonist Therapeutics over the last few years. It is Protagonist Therapeutics' Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Protagonist Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Net Working Capital | 10 Years Trend |
|
Net Working Capital |
Timeline |
Protagonist Net Working Capital Regression Statistics
Arithmetic Mean | 162,280,236 | |
Geometric Mean | 146,492,488 | |
Coefficient Of Variation | 50.96 | |
Mean Deviation | 71,255,515 | |
Median | 108,392,000 | |
Standard Deviation | 82,696,865 | |
Sample Variance | 6838.8T | |
Range | 225.9M | |
R-Value | 0.77 | |
Mean Square Error | 3041.1T | |
R-Squared | 0.59 | |
Significance | 0.0009 | |
Slope | 14,168,510 | |
Total Sum of Squares | 95742.8T |
Protagonist Net Working Capital History
About Protagonist Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Protagonist Therapeutics income statement, its balance sheet, and the statement of cash flows. Protagonist Therapeutics investors use historical funamental indicators, such as Protagonist Therapeutics's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Protagonist Therapeutics investors may use each financial statement separately, they are all related. The changes in Protagonist Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Protagonist Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Protagonist Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Protagonist Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Net Working Capital | 334.3 M | 227.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Protagonist Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Protagonist Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Protagonist Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Protagonist Therapeutics Stock:Check out the analysis of Protagonist Therapeutics Correlation against competitors. For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.Note that the Protagonist Therapeutics information on this page should be used as a complementary analysis to other Protagonist Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Protagonist Stock analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |
Is Protagonist Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagonist Therapeutics. If investors know Protagonist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagonist Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 2.54 | Revenue Per Share 5.308 | Quarterly Revenue Growth (1.00) | Return On Assets 0.2138 | Return On Equity 0.4175 |
The market value of Protagonist Therapeutics is measured differently than its book value, which is the value of Protagonist that is recorded on the company's balance sheet. Investors also form their own opinion of Protagonist Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagonist Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagonist Therapeutics' market value can be influenced by many factors that don't directly affect Protagonist Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagonist Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagonist Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagonist Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.